Bhatt DL - Search Results

1

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T, Maeng M, Merkely B, Zeymer U, Gropper S, Nordaby M, Kleine E, Harper R, Manassie J, Januzzi JL, Ten Berg JM, Steg PG, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators. Cannon CP, et al. Among authors: bhatt dl. N Engl J Med. 2017 Oct 19;377(16):1513-1524. doi: 10.1056/NEJMoa1708454. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844193 Free article. Clinical Trial.

2

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Mukherjee D, et al. Among authors: bhatt dl. Am J Cardiol. 1999 Sep 1;84(5):598-600, A8. doi: 10.1016/s0002-9149(99)00387-2. Am J Cardiol. 1999. PMID: 10482164 Clinical Trial.

3

Corrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction.

Bhatt DL, Ellis SG, Ivanc TB, Crowe T, Balazs E, Debowey D, Pangerl A, Chew PH. Bhatt DL, et al. Am Heart J. 1999 Oct;138(4 Pt 1):785-90. doi: 10.1016/s0002-8703(99)70197-3. Am Heart J. 1999. PMID: 10502228 Clinical Trial.

4

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

Marso SP, Lincoff AM, Ellis SG, Bhatt DL, Tanguay JF, Kleiman NS, Hammoud T, Booth JE, Sapp SK, Topol EJ. Marso SP, et al. Among authors: bhatt dl. Circulation. 1999 Dec 21-28;100(25):2477-84. doi: 10.1161/01.cir.100.25.2477. Circulation. 1999. PMID: 10604884 Clinical Trial.

5

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Bhatt DL, et al. J Am Coll Cardiol. 2000 Mar 15;35(4):922-8. doi: 10.1016/s0735-1097(99)00650-6. J Am Coll Cardiol. 2000. PMID: 10732889 Free article.

6

Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.

Cura FA, Bhatt DL, Lincoff AM, Kapadia SR, L'Allier PL, Ziada KM, Wolski KE, Moliterno DJ, Brener SJ, Ellis SG, Topol EJ. Cura FA, et al. Among authors: bhatt dl. Circulation. 2000 Jul 4;102(1):28-34. doi: 10.1161/01.cir.102.1.28. Circulation. 2000. PMID: 10880411 Clinical Trial.

7

Is the corrected TIMI frame count an independent predictor of adverse outcome?

Bhatt DL, Ellis SG. Bhatt DL, et al. Circulation. 2000 Jul 11;102(2):E19. doi: 10.1161/01.cir.102.2.e19. Circulation. 2000. PMID: 10889146 No abstract available.

8

Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization.

Mukherjee D, Comella K, Bhatt DL, Roe MT, Patel V, Ellis SG. Mukherjee D, et al. Among authors: bhatt dl. Am Heart J. 2001 Jul;142(1):72-4. doi: 10.1067/mhj.2001.115786. Am Heart J. 2001. PMID: 11431659

9

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention.

Chew DP, Bhatt DL, Robbins MA, Penn MS, Schneider JP, Lauer MS, Topol EJ, Ellis SG. Chew DP, et al. Among authors: bhatt dl. Circulation. 2001 Aug 28;104(9):992-7. doi: 10.1161/hc3401.095074. Circulation. 2001. PMID: 11524391

10

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.

Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG. Chew DP, et al. Among authors: bhatt dl. Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6. Am J Cardiol. 2001. PMID: 11564394 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,123 results

Search Page